Development of a self-administrated quality of life questionnaire for sarcopenia in elderly subjects: the SarQoL

Beaudart, Charlotte; Biver, Emmanuel; Reginster, Jean‐Yves; Rizzoli, René; Rolland, Yves; Bautmans, Ivan; Pétermans, Jean; Gillain, Sophie; Buckinx, Fanny; Beveren, Julien Van; Jacquemain, Marc; Italiano, Patrick; Dardenne, Nadia; Bruyère, Olivier

doi:10.1093/ageing/afv133

Cited by 98 publications

(112 citation statements)

References 27 publications

(24 reference statements)

Supporting

Mentioning

102

Contrasting

Unclassified

Order By: Relevance

“…However, this lack is probably because, before last year, no specific quality of life questionnaire for sarcopenia was available in the literature. In 2015, a specific health-related quality of life questionnaire for sarcopenia was developed and validated by our team[42]. It should be very interesting to obtain prospective data about quality of life and its impact on individuals with sarcopenia.…”

Section: Discussionmentioning

confidence: 99%

Health Outcomes of Sarcopenia: A Systematic Review and Meta-Analysis

et al. 2017

Self Cite

View full text Add to dashboard Cite

ObjectiveThe purpose of this study was to perform a systematic review to assess the short-, middle- and long-term consequences of sarcopenia.MethodsProspective studies assessing the consequences of sarcopenia were searched across different electronic databases (MEDLINE, EMBASE, EBM Reviews, Cochrane Database of Systematic Reviews, EBM Reviews ACP Journal Club, EBM Reviews DARE and AMED). Only studies that used the definition of the European Working Group on Sarcopenia in Older People to diagnose sarcopenia were included. Study selection and data extraction were performed by two independent reviewers. For outcomes reported by three or more studies, a meta-analysis was performed. The study results are expressed as odds ratios (OR) with 95% CI.ResultsOf the 772 references identified through the database search, 17 were included in this systematic review. The number of participants in the included studies ranged from 99 to 6658, and the duration of follow-up varied from 3 months to 9.8 years. Eleven out of 12 studies assessed the impact of sarcopenia on mortality. The results showed a higher rate of mortality among sarcopenic subjects (pooled OR of 3.596 (95% CI 2.96–4.37)). The effect was higher in people aged 79 years or older compared with younger subjects (p = 0.02). Sarcopenia is also associated with functional decline (pooled OR of 6 studies 3.03 (95% CI 1.80–5.12)), a higher rate of falls (2/2 studies found a significant association) and a higher incidence of hospitalizations (1/1 study). The impact of sarcopenia on the incidence of fractures and the length of hospital stay was less clear (only 1/2 studies showed an association for both outcomes).ConclusionSarcopenia is associated with several harmful outcomes, making this geriatric syndrome a real public health burden.

show abstract

Section: Discussionmentioning

confidence: 99%

Health Outcomes of Sarcopenia: A Systematic Review and Meta-Analysis

et al. 2017

Self Cite

View full text Add to dashboard Cite

show abstract

“…The method used for the development of the questionnaire has been described elsewhere . Briefly, the development was articulated in the following four stages: (i) item generation—based on literature review, sarcopenic subjects' opinion, experts' opinion, focus groups; (ii) item reduction—based on sarcopenic subjects' and experts' preferences; (iii) questionnaire generation—developed during an expert meeting; and (iv) pre‐test of the questionnaire—based on sarcopenic subjects' opinion.…”

Section: Methodsmentioning

confidence: 99%

“…The method used for the development of the questionnaire has been described elsewhere. 15 Briefly, the development was articulated in the following four stages: (i) item generationbased on literature review, sarcopenic subjects' opinion, experts' opinion, focus groups; (ii) item reduction-based on sarcopenic subjects' and experts' preferences; (iii) questionnaire generation-developed during an expert meeting; and (iv) pre-test of the questionnaire-based on sarcopenic subjects' opinion. A total of 43 sarcopenic subjects and 12 experts (three geriatricians, three rheumatologists expert in the field of bone and muscle, one physiotherapist, one epidemiologist, one linguist expert in the French language, two experts in methodology of questionnaires, and one statistician) were involved in the development of the questionnaire.…”

Section: Development Of the Sarqol®mentioning

confidence: 99%

“…Recently, the Sarcopenia and Quality of Life (SarQoL®), a specific quality of life questionnaire for sarcopenia, has been developed by our team (Appendix S1, also available on http://www.sarqol.org). Before using a questionnaire for clinical and research purposes, one has to ensure that the questionnaire has the appropriate psychometric properties for the intended application.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Validation of the SarQoL®, a specific health‐related quality of life questionnaire for Sarcopenia

Beaudart

Biver²,

Reginster

et al. 2016

J cachexia sarcopenia muscle

Self Cite

182

156

View full text Add to dashboard Cite

BackgroundA specific self‐administrated health‐related quality of life questionnaire for sarcopenia, the Sarcopenia and Quality Of Life (SarQoL®), has been recently developed. This questionnaire is composed of 55 items translated into 22 questions and organized into seven domains of quality of life. The objective of the present work is to evaluate the psychometric properties (discriminative power, validity, reliability, floor and ceiling effects) of the SarQoL® questionnaire.MethodsSarcopenic subjects were recruited in an outpatient clinic in Liège, Belgium and were diagnosed according to the algorithm developed by the European Working Group on Sarcopenia in Older People. We compared the score of the SarQoL® between sarcopenic and non‐sarcopenic subjects using a logistic regression after adjustment for potential confounding variables. Internal consistency reliability was determined using Cronbach's alpha coefficient; construct validity was assessed using convergent and divergent validities. Test–retest reliability was verified after a two‐week interval using the intra‐class correlation coefficient (ICC). At last, floor and ceiling effects were also tested.ResultsA total of 296 subjects with a median age of 73.3 (68.9–78.6) years were recruited for this study. Among them, 43 were diagnosed sarcopenic. After adjustment for potential confounding factors, the total score and the scores of the different dimensions of the SarQoL® questionnaire were significantly lower for sarcopenic than for non‐sarcopenic subjects (54.7 (45.9–66.3) for sarcopenic vs. 67.8 (57.3 – 79.0) for non sarcopenic, OR 0.93 (95%CI 0.90–0.96)). Regarding internal consistency, the Cronbach's alpha coefficient was 0.87. The SarQoL® questionnaire data showed good correlation with some domains of the Short‐Form 36 (SF‐36) and the EuroQoL 5‐dimension (EQ‐5D) questionnaires and with the mobility test. An excellent agreement between the test and the retest was found with an ICC of 0.91 (95% CI 0.82–0.95). At last, neither floor nor ceiling effects were detected.ConclusionsThe SarQoL® questionnaire is valid, consistent, and reliable and can therefore be recommended for clinical and research purposes. However, its sensitivity to change needs to be assessed in future longitudinal studies.

show abstract

“…Other questionnaires like European Quality of Life Questionnaire (EQ )-5D, 80 Older People's Quality of Life questionnaire, 81,82 World Health Organization Quality of Life (WHOQOL)-BREF, 76,83 and Quality of Life Systemic Inventory Questionnaire 84 have also been applied in sarcopenia assessment. Recently, Beaudart et al 85 developed the first self-administrated quality of life questionnaire for sarcopenia in elderly subjects named the Sarcopeniaspecific Quality of Life Questionnaire, which consists of 55 sarcopenic-related items organized into seven domains of dysfunction: physical and mental health, locomotion, body composition, functionality, activities of daily living (ADLs), leisure activities, and fears.…”

Section: Quality Of Lifementioning

confidence: 99%

Management of Sarcopenia to Improve Quality of Life in Geriatric Populations

Zhu²,

Chan³

et al. 2016

Clinical Medicine Insights: Geriatrics

View full text Add to dashboard Cite

Sarcopenia, characterized by a progressive loss of skeletal muscle mass and strength that occurs with advancing age, has been associated with falls, fracture, disability, and mortality. Depending on the definitions used, the prevalence in 60-to 80-year old population is reported as 0.9%-35.9%, while the prevalence ranges from 7%-70.0% in people older than 80 years. Sarcopenia has been associated with lower quality of life. Well-designed exercise interventions, particularly resistance training as well as nutritional supplementation, have been proved to improve muscle strength and performance in geriatric populations. Resistance training may also enhance quality of life. However, there are limited data on the effects of nutritional supplementation as an intervention on quality of life among individuals with sarcopenia. This review briefly summarizes the relationship between sarcopenia and quality of life and presents the potential of interventions to improve muscle quality, physical performance, and quality of life. ACADEMIC EDITOR: atsushi sakuraba, editor in Chief PEER REVIEW: three peer reviewers contributed to the peer review report. Reviewers' reports totaled 497 words, excluding any confidential comments to the academic editor.FUNDING: authors disclose no external funding sources. COMPETING INTERESTS: Authors disclose no potential conflicts of interest.COPYRIGHT: © the authors, publisher and licensee libertas academica limited.this is an open-access article distributed under the terms of the Creative Commons CC-BY-nC 3.0 license. CORRESPONDENCE: rubyyu@cuhk.edu.hkPaper subject to independent expert single-blind peer review. all editorial decisions made by independent academic editor. Upon submission manuscript was subject to anti-plagiarism scanning. Prior to publication all authors have given signed confirmation of agreement to article publication and compliance with all applicable ethical and legal requirements, including the accuracy of author and contributor information, disclosure of competing interests and funding sources, compliance with ethical requirements relating to human and animal study participants, and compliance with any copyright requirements of third parties. this journal is a member of the Committee on Publication ethics (COPe).Provenance: the authors were invited to submit this paper.Published by libertas academica. learn more about this journal. SarcopeniaSarcopenia, defined as a geriatric syndrome characterized by a progressive loss of skeletal muscle mass and strength that occurs with advancing age, was first introduced by Rosenberg in 1989.1,2 The decline in muscle mass occurs after the age of 30 years.3,4 After the age of 50 years, muscle mass is reported to decline at an annual rate of approximately 0.2%; 5 after 70 years, the decline may accelerate to 0.6%-1% per year. [6][7][8] Over the past few decades, refining the definition of sarcopenia has led to significant variation in the meaning. Initially, the definition consists of the measurement of appendicular mass divided...

show abstract

Development of a self-administrated quality of life questionnaire for sarcopenia in elderly subjects: the SarQoL

Cited by 98 publications

References 27 publications

Health Outcomes of Sarcopenia: A Systematic Review and Meta-Analysis

Health Outcomes of Sarcopenia: A Systematic Review and Meta-Analysis

Validation of the SarQoL®, a specific health‐related quality of life questionnaire for Sarcopenia

Management of Sarcopenia to Improve Quality of Life in Geriatric Populations

Contact Info

Product

Resources

About